Inquiry
Form loading...

Daridorexant Hydrochloride: Leading China Suppliers & Reliable Factory for Quality Sleep Solutions

Basic Information

Discover top-quality products from our China-based factory, renowned for its commitment to excellence. As a trusted supplier, we pride ourselves on delivering exceptional value and craftsmanship. Our extensive range of products is designed to meet the diverse needs of customers worldwide. By choosing us, you are partnering with one of the leading suppliers in the industry, ensuring reliable service and superior quality. Explore our offerings and experience the difference that comes from working with a premier factory in China
  • CAS Number 1792993-84-0
  • Molecular Formula C11H19NO4
  • Molucular Weight 229.28
  • Package: 500g/bag, 1kg/bag, 5kg/bag, 10kg/bag, 25kg/drum, or as per customer requirements
  • Storage Sealed and stored at room temperature.
  • Retest Period Two Years

Product Description

Daridorexant hydrochloride, sold under the brand name Quviviq, is a novel dual orexin receptor antagonist (DORA) approved for the treatment of insomnia in adults. It represents a new class of sleep medications that work by specifically targeting the orexin system in the brain, rather than causing general central nervous system (CNS) sedation like traditional hypnotics.

Basic Information & Chemical Properties

Item Details
Drug Class Small molecule dual orexin receptor antagonist (DORA)
Chemical Name (S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride
Molecular Formula C₂₃H₂₄Cl₂N₆O₂
Molecular Weight 487.38 g/mol
CAS Number 1792993-84-0
Physical Appearance White to pale yellow powder, slightly soluble in water
Brand Name Quviviq (Idorsia Pharmaceuticals)
Development Code ACT-541468
Other impurities ≤0.1%
Related Substances - Total Impurities ≤1.0%
Main peak purity ≥99.0%
Chiral purity ≥99.0%
Loss on drying ≤0.5%
Residue on ignition ≤0.1%
Heavy metals ≤10ppm
Storage Sealed and stored at room temperature.

Key Advantages Over Traditional Hypnotics

  • Targeted mechanism: Specifically addresses hyperarousal without general CNS depression
  • Sleep stage preservation: Maintains natural sleep architecture
  • Minimal next-day effects: Short half-life (~8 hours) reduces morning grogginess
  • Lower abuse potential: Schedule IV classification vs. Schedule II for some benzodiazepines
  • Sustained efficacy: Demonstrated effectiveness in clinical trials up to 12 months without tolerance development.

Frequently Asked Questions

Q What is Daridorexant hydrochloride?

Daridorexant hydrochloride, marketed under the brand name Quviviq, is a novel dual orexin receptor antagonist (DORA) developed to treat adults experiencing insomnia.

Q How does Quviviq differ from traditional hypnotics?

Unlike traditional hypnotics that cause general central nervous system (CNS) sedation, Quviviq specifically targets the orexin system in the brain to address hyperarousal while preserving natural sleep architecture.

Q What are the chemical properties of Daridorexant hydrochloride?

It has a molecular formula of C₂₃H₂₄Cl₂N₆O₂ and a molecular weight of 487.38 g/mol. Its CAS number is 1792993-84-0, and it appears as a white to pale yellow powder.

Q Does Daridorexant hydrochloride cause morning grogginess?

It has a short half-life of approximately 8 hours, which helps minimize next-day effects and reduces morning grogginess compared to other sleep medications.

Q How should Daridorexant hydrochloride be stored?

It should be kept sealed and stored at room temperature to maintain its quality and stability.

Q What is the purity standard of the chemical compound?

The chemical compound has a main peak purity of ≥99.0% and a chiral purity of ≥99.0%, with total related impurities restricted to ≤1.0%.

Leave Your Message